Evidence map›Paper›PMID 27402852›Full record

ArticleThe Journal of biological chemistry2016

Insights into Brain Glycogen Metabolism: THE STRUCTURE OF HUMAN BRAIN GLYCOGEN PHOSPHORYLASE.

Cécile Mathieu, Ines Li de la Sierra-Gallay, Romain Duval, Ximing Xu, Angélique Cocaign, Thibaut Léger, Gary Woffendin, Jean-Michel Camadro, Catherine Etchebest, Ahmed Haouz and 2 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
4.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Structural and mechanistic diversity of glycogen phosphorylases from gut bacteria.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  6. Article
  7. Review
  8. Review
  9. Neural Processing without OPhysiology (Bethesda, Md.) · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. Mechanisms of Cadmium Neurotoxicity.International journal of molecular sciences · 2023
    Review
  14. Computational Insights into Novel InhibitorMolecules (Basel, Switzerland) · 2023
    Article
  15. Article
  16. A Novel 5-Chloro-Molecules (Basel, Switzerland) · 2022
    Article
  17. Article
  18. Article
  19. Discovery and Biotechnological Exploitation of Glycoside-Phosphorylases.International journal of molecular sciences · 2022
    Review
  20. Structural Basis for Allostery in PLP-dependent Enzymes.Frontiers in molecular biosciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Cécile MathieuFrom the Université Paris Diderot, Sorbonne Paris Cité, Unité BFA, CNRS UMR 8251, 75013 Paris, France.
Ines Li de la Sierra-Gallaythe Fonction et Architecture des Assemblages Macromoléculaires, Institut de Biologie Intégrative de la Cellule, Université Paris Sud, UMR 9198 Orsay, 91405 France.
Romain DuvalFrom the Université Paris Diderot, Sorbonne Paris Cité, Unité BFA, CNRS UMR 8251, 75013 Paris, France.
Ximing XuFrom the Université Paris Diderot, Sorbonne Paris Cité, Unité BFA, CNRS UMR 8251, 75013 Paris, France.
Angélique CocaignFrom the Université Paris Diderot, Sorbonne Paris Cité, Unité BFA, CNRS UMR 8251, 75013 Paris, France.
Thibaut Légerthe Université Paris Diderot, Sorbonne Paris Cité, Institut Jacques Monod, CNRS UMR 7592, 75013 Paris, France.
Gary WoffendinThermo Fisher Scientific, Hemel Hempstead HP2 7GE, United Kingdom.
Jean-Michel Camadrothe Université Paris Diderot, Sorbonne Paris Cité, Institut Jacques Monod, CNRS UMR 7592, 75013 Paris, France.
Catherine EtchebestINSERM, UMR S1134, Université Paris Diderot, 75015 Paris, France, Université Paris Diderot, Sorbonne Paris Cité, 75004 Paris, France, Institut National de la Transfusion Sanguine, 75015 Paris, France, Laboratoire d'Excellence GR-Ex, 75015 Paris, France, UFR Sciences du Vivant, Université Paris Diderot, 75013 Paris, France, and.
Ahmed Haouzthe Institut Pasteur, Plateforme de Cristallographie, CNRS UMR 3528, 75015 Paris, France.
Jean-Marie DupretFrom the Université Paris Diderot, Sorbonne Paris Cité, Unité BFA, CNRS UMR 8251, 75013 Paris, France, UFR Sciences du Vivant, Université Paris Diderot, 75013 Paris, France, and.
Fernando Rodrigues-LimaFrom the Université Paris Diderot, Sorbonne Paris Cité, Unité BFA, CNRS UMR 8251, 75013 Paris, France, UFR Sciences du Vivant, Université Paris Diderot, 75013 Paris, France, and fernando.rodrigues-lima@univ-paris-diderot.fr.
Centre National de la Recherche Scientifique · FRInserm · FRThermo Fisher Scientific (United Kingdom) · GBUniversité Paris-Sud · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brain glycogen metabolism plays a critical role in major brain functions such as learning or memory consolidation. However, alteration of glycogen metabolism and glycogen accumulation in the brain contributes to neurodegeneration as observed in Lafora disease. Glycogen phosphorylase (GP), a key enzyme in glycogen metabolism, catalyzes the rate-limiting step of glycogen mobilization. Moreover, the allosteric regulation of the three GP isozymes (muscle, liver, and brain) by metabolites and phosphorylation, in response to hormonal signaling, fine-tunes glycogenolysis to fulfill energetic and metabolic requirements. Whereas the structures of muscle and liver GPs have been known for decades, the structure of brain GP (bGP) has remained elusive despite its critical role in brain glycogen metabolism. Here, we report the crystal structure of human bGP in complex with PEG 400 (2.5 Å) and in complex with its allosteric activator AMP (3.4 Å). These structures demonstrate that bGP has a closer structural relationship with muscle GP, which is also activated by AMP, contrary to liver GP, which is not. Importantly, despite the structural similarities between human bGP and the two other mammalian isozymes, the bGP structures reveal molecular features unique to the brain isozyme that provide a deeper understanding of the differences in the activation properties of these allosteric enzymes by the allosteric effector AMP. Overall, our study further supports that the distinct structural and regulatory properties of GP isozymes contribute to the different functions of muscle, liver, and brain glycogen.

Indexed as

Adenosine MonophosphateAllosteric RegulationCrystallography, X-RayGlycogen Phosphorylase, Brain FormHumansIsoenzymesLafora DiseaseNerve Tissue ProteinsProtein DomainsAdenosine MonophosphateGlycogen Phosphorylase, Brain FormIsoenzymesNerve Tissue Proteinsallosteric regulationbrain functionsbrain metabolismcrystal structureenergy metabolismglycogenglycogen metabolismLafora disease (Lafora progressive myoclonic epilepsy, MELF)

Identifiers

PMID27402852
PMCPMC5000057
OpenAlexW2460435846

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.